{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T18:49:17Z","timestamp":1760986157945,"version":"3.37.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T00:00:00Z","timestamp":1674000000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T00:00:00Z","timestamp":1674000000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100010804","name":"Faculty of Medicine, Prince of Songkla University","doi-asserted-by":"publisher","award":["Faculty of Medicine, Prince of Songkla University"],"award-info":[{"award-number":["Faculty of Medicine, Prince of Songkla University"]}],"id":[{"id":"10.13039\/501100010804","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"DOI":"10.1007\/s11239-023-02769-y","type":"journal-article","created":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T08:03:58Z","timestamp":1674029038000},"page":"527-535","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Risk of thrombosis in essential thrombocythemia according to three prediction models: an external validation study"],"prefix":"10.1007","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3900-460X","authenticated-orcid":false,"given":"Pirun","family":"Saelue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paramee","family":"Thongsukhsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,18]]},"reference":[{"key":"2769_CR1","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.blre.2016.06.001","volume":"30","author":"T Barbui","year":"2016","unstructured":"Barbui T, Thiele J, Gisslinger H, Finazzi G, Vannucchi AM, Tefferi A (2016) The 2016 revision of WHO classification of myeloproliferative neoplasms: clinical and molecular advances. Blood Rev 30:453\u2013459","journal-title":"Blood Rev"},{"key":"2769_CR2","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.3324\/haematol.13346","volume":"93","author":"F Passamonti","year":"2008","unstructured":"Passamonti F, Rumi E, Arcaini L, Boveri E, Elena C, Pietra D et al (2008) Prognostic factors for thrombosis, myelofibrosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients. Haematologica 93:1645\u20131651","journal-title":"Haematologica"},{"key":"2769_CR3","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1182\/blood-2014-05-579136","volume":"124","author":"A Tefferi","year":"2014","unstructured":"Tefferi A, Guglielmelli P, Larson DR, Finke C, Wassie EA, Pieri L et al (2014) Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis. Blood 124:2507\u20132515","journal-title":"Blood"},{"key":"2769_CR4","doi-asserted-by":"publisher","first-page":"263485352097821","DOI":"10.1177\/2634853520978210","volume":"13","author":"V Accurso","year":"2020","unstructured":"Accurso V, Santoro M, Mancuso S, Napolitano M, Carlisi M, Mattana M et al (2020) The essential thrombocythemia in 2020: what we know and where we still have to dig deep. Clin Med Insights Blood Disord 13:2634853520978210","journal-title":"Clin Med Insights Blood Disord"},{"key":"2769_CR5","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1002\/ajh.23685","volume":"89","author":"M Montanaro","year":"2014","unstructured":"Montanaro M, Lataglita R, Cedrone M, Spadea A, Rago A, Di Giandomenico J et al (2014) Thrombosis and survival in essential thrombocythemia: a regional study of 1,144 patients. Am J Hematol 89:542\u2013546","journal-title":"Am J Hematol"},{"key":"2769_CR6","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1200\/JCO.1990.8.3.556","volume":"8","author":"S Cortelazzo","year":"1990","unstructured":"Cortelazzo S, Viero P, Finazzi G, D\u2019Emilio A, Rodeghiero F, Barbui T (1990) Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia. J Clin Oncol 8:556\u2013562","journal-title":"J Clin Oncol"},{"key":"2769_CR7","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/sj.leu.2401270","volume":"13","author":"C Besses","year":"1999","unstructured":"Besses C, Cervantes F, Pereira A, Florensa L, Sol\u0117 F, Herm\u00e1ndez-Boluda JC et al (1999) Major vascular complications in essential thrombocythemia: a study of the predictive factors in a series of 148 patients. Leukemia 13:150\u2013154","journal-title":"Leukemia"},{"key":"2769_CR8","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1001\/archinte.165.22.2651","volume":"165","author":"CS Chim","year":"2005","unstructured":"Chim CS, Kwong YL, Lie AK, Ma SK, Chan CC, Wong LG et al (2005) Long-term outcome of 231 patients with essential thrombocythemia: prognostic factors for thrombosis, bleeding, myelofibrosis, and leukemia. Arch Intern Med 165:2651\u20132658","journal-title":"Arch Intern Med"},{"key":"2769_CR9","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/j.1365-2141.2005.05858.x","volume":"132","author":"B Cheung","year":"2006","unstructured":"Cheung B, Radia D, Pantelidis P, Yadegarfar G, Harrison C (2006) The presence of the JAK2V617F mutation is associated with a higher haemoglobin and increased risk of thrombosis in essential thrombocythaemia. Br J Haematol 132:244\u2013245","journal-title":"Br J Haematol"},{"key":"2769_CR10","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1016\/S0140-6736(05)67785-9","volume":"366","author":"PJ Campbell","year":"2005","unstructured":"Campbell PJ, Scott LM, Buck G, Wheatley K, East CL, Marsden JT et al (2005) Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2V617F mutation status: a prospective study. Lancet 366:1945\u20131953","journal-title":"Lancet"},{"key":"2769_CR11","doi-asserted-by":"publisher","first-page":"5128","DOI":"10.1182\/blood-2012-07-444067","volume":"120","author":"T Barbui","year":"2012","unstructured":"Barbui T, Finazzi G, Carobbio A, Thiele J, Passamonti F, Rumi E et al (2012) Development and validation of an International Prognostic score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis). Blood 120:5128\u20135133","journal-title":"Blood"},{"key":"2769_CR12","doi-asserted-by":"publisher","first-page":"e369","DOI":"10.1038\/bcj.2015.94","volume":"5","author":"T Barbui","year":"2015","unstructured":"Barbui T, Vannucchi AM, Buxhofer-Ausch V, De Stefano V, Betti S, Rambaldi A et al (2015) Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemia. Blood Cancer J 5:e369","journal-title":"Blood Cancer J"},{"key":"2769_CR13","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1002\/ajh.26008","volume":"95","author":"A Tefferi","year":"2020","unstructured":"Tefferi A, Barbui T (2020) Polycythemia vera and essential thrombocythemia: 2021 update on diagnosis, risk-stratification and management. Am J Hematol 95:1599\u20131613","journal-title":"Am J Hematol"},{"key":"2769_CR14","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/ejh.12275","volume":"92","author":"R Fu","year":"2014","unstructured":"Fu R, Xuan M, Lv C, Zhang L, Li H, Zhang X et al (2014) External validation and clinical evaluation of the International Prognostic score of thrombosis for essential thrombocythemia (IPSET-thrombosis) in a large cohort of chinese patients. Eur J Haematol 92:502\u2013509","journal-title":"Eur J Haematol"},{"key":"2769_CR15","doi-asserted-by":"publisher","first-page":"e101","DOI":"10.1016\/j.clml.2015.02.004","volume":"15","author":"OG Sevindik","year":"2015","unstructured":"Sevindik OG, Mersin S, Katgi A, Tunali S, Solmaz SM, Acar C et al (2015) IPSET-thrombosis better identifies thrombosis-free survival: a turkish cohort. Clin Lymphoma Myeloma Leuk 15:e101\u2013e104","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"2769_CR16","doi-asserted-by":"crossref","unstructured":"Navarro LM, Trufelli DC, Bonito DR, Giglio AD (2016) Application of prognostic score IPSET-thrombosis in patients with essential thrombocythemia of a Brazilian public service. Rev Assoc Med Bras (1992) 62:647\u201351","DOI":"10.1590\/1806-9282.62.07.647"},{"key":"2769_CR17","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.medcli.2014.04.029","volume":"144","author":"A Angona","year":"2015","unstructured":"Angona A, Alvarez-Larr\u00e1n A, Bellosillo B, Mart\u00ednez-Avil\u00e9s L, Garcia-Pallarols F, Longar\u00f3n R et al (2015) Essential thrombocythemia: baseline characteristics and risk factors for survival and thrombosis in a series of 214 patients. Med Clin (Barc) 144:247\u2013253","journal-title":"Med Clin (Barc)"},{"key":"2769_CR18","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1002\/ajh.24293","volume":"91","author":"M Haider","year":"2016","unstructured":"Haider M, Gangat N, Lasho T, Hussein AKA, Elala YC, Hanson C et al (2016) Validation of the revised International Prognostic score of thrombosis for essential thrombocythemia (IPSET-thrombosis) in 585 Mayo Clinic patients. Am J Hematol 91:390\u2013394","journal-title":"Am J Hematol"},{"key":"2769_CR19","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/ejh.13136","volume":"101","author":"Y Hashimoto","year":"2018","unstructured":"Hashimoto Y, Nakamae H, Tanaka T, Omura H, Horiuchi M, Yoshimura T et al (2018) Validation of previous prognostic models for thrombosis and exploration of modified models in patients with essential thrombocythemia. Eur J Haematol 101:508\u2013513","journal-title":"Eur J Haematol"},{"key":"2769_CR20","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1080\/16078454.2021.2022848","volume":"27","author":"T Baba","year":"2022","unstructured":"Baba T, Hashimoto Y, Yasuda H, Araki M, Edahiro Y, Morishita S et al (2022) Validation and reliability of current guidelines for the treatment of essential thrombocythemia under real-world clinical settings in Japan. Hematology 27:157\u2013166","journal-title":"Hematology"},{"key":"2769_CR21","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12959-017-0155-z","volume":"16","author":"KL Wang","year":"2018","unstructured":"Wang KL, Yap ES, Goto S, Zhang S, Siu CW, Chiang CE (2018) The diagnosis and treatment of venous thromboembolism in asian patients. Thromb J 16:4","journal-title":"Thromb J"},{"key":"2769_CR22","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1160\/TH17-02-0134","volume":"117","author":"LH Lee","year":"2017","unstructured":"Lee LH, Gallus A, Jindal R, Wang C, Wu CC (2017) Incidence of venous thromboembolism in asian populations: a systematic review. Thromb Haemost 117:2243\u20132260","journal-title":"Thromb Haemost"},{"key":"2769_CR23","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1182\/blood-2016-05-643346","volume":"128","author":"E Rumi","year":"2016","unstructured":"Rumi E, Cazzola M (2016) How I treat essential thrombocythemia. Blood 128:2403\u20132414","journal-title":"Blood"},{"key":"2769_CR24","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.3348\/kjr.2021.0223","volume":"22","author":"SY Park","year":"2021","unstructured":"Park SY, Park JE, Kim H, Park SH (2021) Review of statistical methods for evaluating the performance of survival or other Time-to-event Prediction Models (from Conventional to Deep Learning Approaches). Korean J Radiol 22:1697\u20131707","journal-title":"Korean J Radiol"},{"key":"2769_CR25","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s10985-015-9330-3","volume":"22","author":"G Heller","year":"2016","unstructured":"Heller G, Mo Q (2016) Estimating the concordance probability in a survival analysis with a discrete number of risk groups. Lifetime Data Anal 22:263\u2013279","journal-title":"Lifetime Data Anal"},{"key":"2769_CR26","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1093\/ejcts\/ezy180","volume":"54","author":"SW Grant","year":"2018","unstructured":"Grant SW, Collins GS, Nashef SAM (2018) Statistical primer: developing and validating a risk prediction model. Eur J Cardiothorac Surg 54:203\u2013208","journal-title":"Eur J Cardiothorac Surg"},{"key":"2769_CR27","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/jth.12262","volume":"11","author":"JMT Hendriksen","year":"2013","unstructured":"Hendriksen JMT, Geersing GJ, Moons KGM, de Groot JAH (2013) Diagnostic and prognostic prediction models. J Thromb Haemost 11:129\u2013141","journal-title":"J Thromb Haemost"},{"key":"2769_CR28","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1002\/ajh.24882","volume":"92","author":"A Tefferi","year":"2017","unstructured":"Tefferi A, Betti S, Barraco D, Mudireddy M, Shah S, Hanson CA et al (2017) Gender and survival in essential thrombocythemia: a two-center study of 1,494 patients. Am J Hematol 92:1193\u20131197","journal-title":"Am J Hematol"},{"key":"2769_CR29","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1046\/j.1365-2141.2002.03688.x","volume":"118","author":"F Cervantes","year":"2002","unstructured":"Cervantes F, Alvarez-Larr\u00e1n A, Talarn C, G\u00f3mez M, Montserrat E et al (2002) Myelofibrosis with myeloid metaplasia following essential thrombocythaemia: actuarial probability, presenting characteristics and evolution in a series of 195 patients. Br J Haematol 118:786\u2013790","journal-title":"Br J Haematol"},{"key":"2769_CR30","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/1097-0142(19900801)66:3<549::AID-CNCR2820660324>3.0.CO;2-6","volume":"66","author":"P Fenaux","year":"1990","unstructured":"Fenaux P, Simon M, Caulier MT, Lai JL, Goudemand J, Bauters F (1990) Clinical course of essential thrombocythemia in 147 cases. Cancer 66:549\u2013556","journal-title":"Cancer"},{"key":"2769_CR31","doi-asserted-by":"publisher","first-page":"865","DOI":"10.3324\/haematol.2008.004234","volume":"94","author":"F Girodon","year":"2009","unstructured":"Girodon F, Bonicelli G, Schaeffer C, Mounier M, Carillo S, Lafon I et al (2009) Significant increase in the apparent incidence of essential thrombocythemia related to new WHO diagnostic criteria: a population-based study. Haematologica 94:865\u2013869","journal-title":"Haematologica"},{"key":"2769_CR32","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.amjmed.2004.06.032","volume":"117","author":"F Passamonti","year":"2004","unstructured":"Passamonti F, Rumi E, Pungolino E, Malabarba L, Bertazzoni P, Valentini M et al (2004) Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia. Am J Med 117:755\u2013761","journal-title":"Am J Med"},{"key":"2769_CR33","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(05)71142-9","volume":"365","author":"EJ Baxter","year":"2005","unstructured":"Baxter EJ, Scott LM, Campbell PJ, East C, Fourouclas N, Swanton S et al (2005) Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 365:1054\u20131061","journal-title":"Lancet"},{"key":"2769_CR34","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1080\/01621459.1988.10478722","volume":"83","author":"RJA Little","year":"1988","unstructured":"Little RJA (1988) A test of missing completely at random for multivariate data with missing values. J Am Stat Assoc 83:1198\u20131202","journal-title":"J Am Stat Assoc"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-023-02769-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-023-02769-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-023-02769-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T05:20:42Z","timestamp":1681795242000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-023-02769-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,18]]},"references-count":34,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["2769"],"URL":"https:\/\/doi.org\/10.1007\/s11239-023-02769-y","relation":{},"ISSN":["1573-742X"],"issn-type":[{"type":"electronic","value":"1573-742X"}],"subject":[],"published":{"date-parts":[[2023,1,18]]},"assertion":[{"value":"2 January 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}